Navigation Links
AlphaCor™ Artificial Cornea

ProductsAlphaCor™ Artificial Cornea
Company CooperVision Surgical
Item AlphaCor™ Artificial Cornea
Features Design:
AlphaCor is a one piece convex disc consisting of a central transparent optic and an outer skirt that is entirely manufactured from poly (2 hydroxyethyl methacrylate) or PHEMA. AlphaCors material and patented features are designed to promote retention and optimize patient outcomes.

Outer Skirt:
The outer skirt is an opaque, high water content, PHEMA sponge. The porosity of the sponge encourages biointegration with host tissue and thus promotes retention of the implanted device.

Central Optic:
The central optic core is a transparent PHEMA gel providing a refractive power similar to that of the human cornea. The optic core is designed to allow the patients visual potential to be achieved.

The Interpenetrating Polymer Network (IPN):
The junctional zone between the skirt and central optic is the Interpenetrating Polymer Network or IPN. This is a permanent bond formed at the molecular level and is designed to prevent the down-growth of cells around the optic, which can lead to the formation of retroprosthetic membranes, one of the major complications historically associated with artificial corneas.
Description AlphaCor is a biocompatible, flexible, one-piece artificial cornea (keratoprosthesis) designed to replace a scarred or diseased native cornea.

The World Health Organisation (WHO) reports that corneal blindness affects more than 10 million people worldwide, however only 100,000 people receive corneal transplants each year. This shortfall is due to a combination of inadequate supply of donor corneas and the unsuitability of some patients to receive a corneal graft.

AlphaCor is designed for use in patients who have had multiple failed corneal transplants or in those patients in whom a donor graft is likely to fail.

Its patented design features are aimed to promote retention, minimize post-operative complications and restore vision in patients who cannot receive, or are unlikely to have a beneficial outcome from, a human donor graft.

AlphaCor is available in two versions, to suit those with a natural lens (phakic) or artificial lens (pseudophakic) and for those without a lens (aphakic).

Info CooperVision Surgical
Customer Service: (888) 822-2660 x3320
Web site: http://www.coopervisionsurgical.com/

Related medicine products :

1. Castroviejo Corneal Trephine Set
2. Machat Corneal Spatula
3. Storz Corneal Burr
4. Handle for Corneal Burrs
5. Pediatric Corneal Shields 10/Box
6. Corneal Crouch Protector
7. Welch Allyn PanOptic Ophthalmoscope with Cobalt-Blue Filter and Corneal Viewing Lens
8. Catalano Corneal Scleral Forceps - 0.12 mm
9. Katzin-Barraquer Corneal Utility Forceps, Colibri Style
10. Harms Corneal Utility Forceps, Colibri Style
11. Storz Corneal Forceps, Colibri Style
...s full weight. Footstep tilts out of the way when ...ed and lowered by either a finger switch on both s... Dual rotation locks on both sides of the chair en...position. A patented recline handle which is easil...
Video Equipment
Heine Beta 200 Streak Retinoscope 3.5v
Keeler Professional Combi Retinoscope with new slimline handle and lithium or dry cell option.
Medicine Products:
(Date:5/16/2008)...er Seeks to Raise $38 Million for Life-threatening...swire/ -- Walkers in nearly,every state will raise...and,18 -- by participating in GREAT STRIDES, the l...s Foundation announced today., May is National Cy...a,life-threatening genetic disease that causes fat...
(Date:5/16/2008)...ds is more unemployed politicians - and economists...- Although nearly all,voters place health care at ...ooming federal budgetary crunch means none of the ...residential candidates is likely to become,law any... Bill Frist., Jousting with Princeton University ...
(Date:5/16/2008).../PRNewswire-USNewswire/ -- As tropical storms,cont...delta, survivors of,Cyclone Nargis are vulnerable ...ors still need assistance, as exposure to the foul...ngly dire situation., "The people living in these...m this disaster and get back on their feet," said ...
(Date:5/16/2008)...f., May 16 /PRNewswire-FirstCall/ -- Nationwide,He...y the promotion of David,M. Boitano to Senior Vice...s made a tremendous contribution to NHP over the l...tment growth and diversification strategy,successe...n accretive,investments for NHP, leveraging his va...
Breaking Medicine News(10 mins):Health News:GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 3Health News:Myanmar Cyclone Survivors Face New Challenges 2Health News:David M. Boitano Promoted to Senior Vice President 2
...sday asked the government, the railway ministry an...CTC) to reply to a petition accusing them of suppl...ion bench comprising judges M.K. Sharma and Reva K...he respondents to file their replies by July 19. ...
...fluenza pandemic set into action by mutations of t... we to handle// a mega crisis, and what plan of ac... the responses to an epidemic, eight Asia Pacific ... mock drill that will gauge the effectiveness of a...
...gners have termed the plans for slow suffocation o...outbreak as inhumane//. According to Compassion i...ughter and Killing) regulations 1995 have been ame...the Secretary of State has been authorized for "ve...
...wett Research Institute and Aberdeen University in...ic acid were more likely to have twins// following...ement might be linked to higher rates of multiple ...ever, the researchers said that folic acid, a vita...
Other Medicine News:Health News:High Levels Of Folic Acid May Increase The Chances Of Twins After IVF 2
(Date:5/16/2008)...gy Enables First-Ever PEGylation of a Small Molecu... Activity, SAN CARLOS, Calif., May 16 /PRNewswire...) announced initial results today from a Phase 1,s...shows significant,anti-tumor activity in patients ...strates that Nektar,s small molecule PEGylation te...
(Date:5/15/2008)...onfirm Efficacy for Population Most Affected by Di...16 /-,Bayer HealthCare Phar...Nasdaq: ONXX ) today announced that Nexavar(R) (s...urvival by 47.3 percent (HR=0.68;,p-value=0.014) i...d,hepatocellular carcinoma (HCC), or primary liver...
(Date:5/15/2008)...cacy Clinical Data from Prostate, Colorectal and O... Company to Hold Investor Event on Sun., June 1 wi...., May 15 /- Poniard,Pharma...cal company focused,on oncology, today announced t...cal trials of picoplatin, in various tumor types a...
(Date:5/15/2008)...uctions demonstrated in Blacks, Hispanics/Latinos,...ndividuals, PARSIPPANY, N.J., May 15 /PRNewswire/...a presented at the American Society of,Hypertensio...008) in New,Orleans demonstrated that the powerful...tan medoxomil) safely and effectively helped,patie...
Breaking Medicine Technology:Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 2Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 4Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 2Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 3Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 4Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7Finola Hughes Announces Her Best Accessory at Fashion Week 10829 1Finola Hughes Announces Her Best Accessory at Fashion Week 10829 2Finola Hughes Announces Her Best Accessory at Fashion Week 10829 3Natural Nutrition Operating Subsidiary Reports Record 29 25 Increase in Revenues for 2007 of 2417 460 000 10827 1Natural Nutrition Operating Subsidiary Reports Record 29 25 Increase in Revenues for 2007 of 2417 460 000 10827 2Diagnostic Centers of America Retains NewsMark Public Relations to Showcase Its Rise as Only Medical Facility in South Florida With Worlds Most Advanc 10823 1Diagnostic Centers of America Retains NewsMark Public Relations to Showcase Its Rise as Only Medical Facility in South Florida With Worlds Most Advanc 10823 2Synosia Therapeutics Appoints Chief Financial Officer to New Company Headquarters in Switzerland 2951 1Synosia Therapeutics Appoints Chief Financial Officer to New Company Headquarters in Switzerland 2951 2
...Impact of Pain on Sleep Interference, INDIANAPOLIS... a,pooled analysis of three studies suggest that i...ge, or diabetic peripheral neuropathy,who are tre...in,both average daily pain and night pain severity...rference than in those patients,taking sugar pill....
...SX Venture Exchange, EDMONTON, May 02, 2007 /PRNew...or the "Company") Quest is pleased to provide an,u... the treatment,of prostate cancer. , Prostate canc...American men with approximately 230,000 new cases ...dalities for localized prostate,cancer are associa...
Other Medicine Technology:Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 2Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 3Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 4Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 5Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 6Quest PharmaTech's Prostate Cancer Program Update 2Quest PharmaTech's Prostate Cancer Program Update 3